Blue Star vs Parker-Hannifin

Blue Star and Parker-Hannifin are two prominent stocks in the market, each with its own unique qualities and potential for growth. Blue Star is a leading air conditioning and commercial refrigeration company, known for its reliable products and strong presence in the industry. On the other hand, Parker-Hannifin is a diversified manufacturer and supplier of motion and control technologies, catering to a wide range of industries. Both stocks have shown promising performance in recent years, making them attractive options for investors looking for stability and potential returns.

Blue Star

Parker-Hannifin

Stock Price
Day Low₹2018.00
Day High₹2096.95
Year Low₹814.00
Year High₹2199.55
Yearly Change170.21%
Revenue
Revenue Per Share₹502.14
5 Year Revenue Growth0.74%
10 Year Revenue Growth1.93%
Profit
Gross Profit Margin0.19%
Operating Profit Margin0.07%
Net Profit Margin0.05%
Stock Price
Day Low$637.66
Day High$646.60
Year Low$362.49
Year High$646.60
Yearly Change78.38%
Revenue
Revenue Per Share$154.94
5 Year Revenue Growth0.38%
10 Year Revenue Growth0.70%
Profit
Gross Profit Margin0.36%
Operating Profit Margin0.19%
Net Profit Margin0.14%

Blue Star

Parker-Hannifin

Financial Ratios
P/E ratio84.17
PEG ratio8.87
P/B ratio16.12
ROE20.16%
Payout ratio0.00%
Current ratio0.00
Quick ratio0.00
Cash ratio0.00
Dividend
Dividend Yield0.34%
5 Year Dividend Yield31.95%
10 Year Dividend Yield19.62%
Blue Star Dividend History
Financial Ratios
P/E ratio28.85
PEG ratio-3.89
P/B ratio6.80
ROE24.99%
Payout ratio27.50%
Current ratio0.93
Quick ratio0.55
Cash ratio0.06
Dividend
Dividend Yield0.97%
5 Year Dividend Yield14.44%
10 Year Dividend Yield12.48%
Parker-Hannifin Dividend History

Blue Star or Parker-Hannifin?

When comparing Blue Star and Parker-Hannifin, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Blue Star and Parker-Hannifin.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Blue Star has a dividend yield of 0.34%, while Parker-Hannifin has a dividend yield of 0.97%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Blue Star reports a 5-year dividend growth of 31.95% year and a payout ratio of 0.00%. On the other hand, Parker-Hannifin reports a 5-year dividend growth of 14.44% year and a payout ratio of 27.50%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Blue Star P/E ratio at 84.17 and Parker-Hannifin's P/E ratio at 28.85. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Blue Star P/B ratio is 16.12 while Parker-Hannifin's P/B ratio is 6.80.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Blue Star has seen a 5-year revenue growth of 0.74%, while Parker-Hannifin's is 0.38%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Blue Star's ROE at 20.16% and Parker-Hannifin's ROE at 24.99%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ₹2018.00 for Blue Star and $637.66 for Parker-Hannifin. Over the past year, Blue Star's prices ranged from ₹814.00 to ₹2199.55, with a yearly change of 170.21%. Parker-Hannifin's prices fluctuated between $362.49 and $646.60, with a yearly change of 78.38%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.

Comparision